Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Peri-Transplant Steroids Enhance GVL and Attenuate GVHD By Redistributing Alloreactive Donor T Cells from the Gut into the Bone Marrow

Takayuki Inouye, MD PhD, Motoko Koyama, MD PhD, Ensbey Kathleen, Nicholas Greene, Luke Samson, Hiroyasu Ogawa, MD PhD, Geoffrey R. Hill, MD

Blood (2019) 134 (Supplement_1): 3210.

https://doi.org/10.1182/blood-2019-129341

Published: 2019

Journal Articles

Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia Harboring t(7;11)(p15;p15)

Kaito Harada, MD, Noriko Doki, Jun Aoki, MD, Jinichi Mori, MD, Shinichiro Machida, MD, Yuho Najima, Naoyuki Uchida, MD PhD, Takahiro Fukuda, MD, Heiwa Kanamori, MD, Hiroyasu Ogawa, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Shingo Yano, MD PhD

Blood (2016) 128 (22): 4654.

https://doi.org/10.1182/blood.V128.22.4654.4654

Published: 2016

Journal Articles

The Safety of Hematopoietic Stem Cell Harvest from Elderly Family Donor in Japan

Tsutomu Takahashi, Ritsuro Suzuki, Hiroyasu Ogawa, MD PhD, Takahiro Fukuda, MD, Kazuteru Ohashi, Shuichi Taniguchi, Yoshinobu Kanda, MD PhD, Hiromasa Abe, Yoshihisa Kodera, MD, Junji Suzumiya, MD PhD

Blood (2015) 126 (23): 1897.

https://doi.org/10.1182/blood.V126.23.1897.1897

Published: 2015

Journal Articles

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation: A Multi-Center Study in Japan

Blood (2015) 126 (23): 4341.

https://doi.org/10.1182/blood.V126.23.4341.4341

Published: 2015

Journal Articles

Second Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Relapse of Hematological Malignancies after First Allo-HSCT

Koji Kato, MD PhD, Toshihiro Miyamoto, MD PhD, Koji Yonemoto, PhD, Naoyuki Uchida, MD PhD, Hiroyasu Ogawa, MD PhD, Takahiro Fukuda, MD, Satoshi Takahashi, MD, Kazuteru Ohashi, MD FACP, Tetsuya Eto, MD PhD, Tokiko Nagamura-Inoue, Hisashi Sakamaki, MDPhD, Yasuo Morishima, MD, Ritsuro Suzuki, MD PhD, Yoshiko Atsuta, MDPhD, Koichi Akashi, MD PhD

Blood (2014) 124 (21): 3947.

https://doi.org/10.1182/blood.V124.21.3947.3947

Published: 2014

Journal Articles

Influence Of Donor Source On Relapse and Survival In Patients With Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis From The Japan Society For Hematopoietic Cell Transplantation (JSHCT) AML Working Group

Shingo Yano, MD, Hiroki Yokoyama, MD, Naoyuki Uchida, MD, PhD, Kazuhiko Kakihana, MD, PhD, Takahiro Fukuda, MD, Heiwa Kanamori, MD, Hiroyasu Ogawa, MD, PhD, Tokiko Nagamura, MD, PhD, Junji Tanaka, MD, PhD, Yasuo Morishima, MD, Yoshiko Atsuta, MD, Akiyoshi Takami, MD, PhD

Blood (2013) 122 (21): 3361.

https://doi.org/10.1182/blood.V122.21.3361.3361

Published: 2013

Journal Articles

FDG-PET/CT Early After 90Y-Ibritumomab Tiuxetan Therapy Predicts Outcome in Relapsed or Refractory Indolent B-Cell Lymphoma

Masaya Okada, MD, PhD, Yoshihiro Fujimori, MD, PhD, Naohiko Oku, MD, PhD, Akira Tamekane, MD, PhD, Toshiro Takafuta, MD, PhD, Toshiyuki Nakajima, MD, Tazuko Tokugawa, MD, Akihiro Sawada, MD, Shin-ichi Ishii, MD, Katsuji Kaida, MD, Kazuhiro Ikegame, MD, PhD, Toshihiro Soma, MD, PhD, Hiroyasu Ogawa, MD, PhD

Blood (2012) 120 (21): 3648.

https://doi.org/10.1182/blood.V120.21.3648.3648

Published: 2012

Journal Articles

A Novel Regimen of Unmanipulated HLA-Haploidentical Transplantation Using a Small Dose of Anti-T-Lymphocyte Globulin for Patients in High Tumor Burden

Shinichi Ishii, MD, Kazuhiro Ikegame, MD, PhD, Katsuji Kaida, MD, Satoshi Yoshihara, MD, PhD, Masaya Okada, MD, PhD, Ruri Kato, MD, Takayuki Inoue, MD, Hiroya Tamaki, MD, PhD, Yoshihiro Fujimori, MD, PhD, Toshihiro Soma, Hiroyasu Ogawa, MD, PhD

Blood (2012) 120 (21): 4203.

https://doi.org/10.1182/blood.V120.21.4203.4203

Published: 2012

Journal Articles

Novel Strategy for MDS with Thalidomide, 5-Azacitidine and Stem Cell Transplantaion

Kunio Hayashi, M.D., Ph.D., Kazuhiro Ikegame, MD, PhD, Hiroyasu Ogawa, M.D., Ph.D.

Blood (2012) 120 (21): 4960.

https://doi.org/10.1182/blood.V120.21.4960.4960

Published: 2012

Journal Articles

Unmanipulated HLA-Haploidentical (2-3 antigen-mismatched) Stem Cell Transplantation Using Myeloablative or Reduced-Intensity Preconditioning Regimen,

Katsuji Kaida, MD, Kazuhiro Ikegame, MD, PhD, Satoshi Yoshihara, MD, PhD, Kyoko Taniguchi, MD, Shinichi Ishii, MD, Ruri Kato, MD, Takayuki Inoue, MD, Masaya Okada, MD, PhD, Hiroya Tamaki, MD, PhD, Tatsuya Fujioka, MD, PhD, Toshihiro Soma, MD, PhD, Hiroyasu Ogawa, MD, PhD

Blood (2011) 118 (21): 4117.

https://doi.org/10.1182/blood.V118.21.4117.4117

Published: 2011

Journal Articles

Prognostic Factors of Reducing Relapse in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation From Related Donor for Acute Myeloid Leukemia: The Japan Society for Hematopoietic Cell Transplantation (JSHCT) AML Working Group

Shingo Yano, MD, Hiroki Yokoyama, MD, Rimei Nishimura, MD, Takahiro Fukuda, MD, Hiroyasu Ogawa, MD, PhD, Kazuteru Ohashi, MD, PhD, Heiwa Kanamori, MD, Junji Tanaka, MD, Hisashi Sakamaki, MD, Yoshiko Atsuta, MD, Akiyoshi Takami, MD PhD

Blood (2011) 118 (21): 3085.

https://doi.org/10.1182/blood.V118.21.3085.3085

Published: 2011

Journal Articles

Prospective Isolation and Functional Characterization of Human Bone Marrow-Derived Hematopoietic Stem Cell-Supportive Mesenchymal Stromal Cells.

Yoshikazu Matsuoka, PhD, Yutaka Sasaki, MD, PhD, Masaya Takahashi, MD, Ryusuke Nakatsuka, PhD, Yasushi Uemura, MD, PhD, Masami Inoue, MD, Hiroyasu Ogawa, MD, PhD, Takayuki Takahashi, MD, PhD, Jun Ishikawa, MD, Masayuki Hino, MD, PhD, Yoshiaki Sonoda, MD, PhD

Blood (2010) 116 (21): 3852.

https://doi.org/10.1182/blood.V116.21.3852.3852

Published: 2010

Journal Articles

Mechanism of Marked Reduction In the Severity of Graft-Versus-Host Disease by Reduced-Intensity Conditioning In Murine MHC-Haploidentical BMT Model

Takayuki Inoue, Kazuhiro Ikegame, Satoshi Yoshihara, Katsuji Kaida, Kyoko Taniguchi, Hiroya Tamaki, Tatsuya Fujioka, Masaya Okada, Ruri Kato, Yoko Yamamoto, Toshihiro Soma, Hiroyasu Ogawa

Blood (2010) 116 (21): 4707.

https://doi.org/10.1182/blood.V116.21.4707.4707

Published: 2010

Journal Articles

Allogeneic stem cell transplantation for adult Philadelphia chromosome–negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission

Satoshi Nishiwaki, Yoshihiro Inamoto, Hisashi Sakamaki, Mineo Kurokawa, Hiroatsu Iida, Hiroyasu Ogawa, Takahiro Fukuda, Yukiyasu Ozawa, Naoki Kobayashi, Masanobu Kasai, Takehiko Mori, Koji Iwato, Takashi Yoshida, Makoto Onizuka, Keisei Kawa, Yasuo Morishima, Ritsuro Suzuki, Yoshiko Atsuta, Koichi Miyamura

Blood (2010) 116 (20): 4368–4375.

https://doi.org/10.1182/blood-2010-02-269571

Published: 2010

Journal Articles

Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes

Yachiyo Kuwatsuka, Koichi Miyamura, Ritsuro Suzuki, Masaharu Kasai, Atsuo Maruta, Hiroyasu Ogawa, Ryuji Tanosaki, Satoshi Takahashi, Kyuhei Koda, Kazuhiro Yago, Yoshiko Atsuta, Takashi Yoshida, Hisashi Sakamaki, Yoshihisa Kodera

Blood (2009) 113 (9): 2096–2103.

https://doi.org/10.1182/blood-2008-03-145862

Published: 2009

Includes: Supplemental data

Journal Articles

Association of TLR-4 Mutations in Host and Donor Cells and the Risk for Acute GVHD after Allogeneic Hematopoietic Stem Cell Transplantation.

Takehito Imado, PhD, Tsuyoshi Iwasaki, Ph.D, Takanori Kuroiwa, Ph.D, Sachie Kitano, M.D, Hajime Sano, Ph.D, Hiroyasu Ogawa, Ph.D

Blood (2006) 108 (11): 3235.

https://doi.org/10.1182/blood.V108.11.3235.3235

Published: 2006

Journal Articles

Infusions of Fresh Frozen Plasma to the Patients with a High-Risk Group for Hepatic VOD Associated with Stem Cell Transplantation Reduce Its Occurrence.

Masanori Matsumoto, MD, Keisei Kawa, MD, Hieo Yagi, MD, Yong-Dong Park, MD, Yasuhiro Takeshima, MD, Yoshiyuki Kosaka, MD, Hiroshi Hara, MD, Shunro Kai, MD, Masuji Yamamoto, MD, Akihisa Kanemaru, MD, Shirou Fukuhara, MD, Masayuki Hino, MD, Masahiko Sako, MD, Akira Hiraoka, MD, Hiroyasu Ogawa, MD, Junichi Hara, MD, Yoshihiro Fujimura, MD

Blood (2006) 108 (11): 1502.

https://doi.org/10.1182/blood.V108.11.1502.1502

Published: 2006

Journal Articles

Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program

Koji Izutsu, Yoshinobu Kanda, Hitoshi Ohno, Hiroshi Sao, Hiroyasu Ogawa, Yasushi Miyazaki, Keisei Kawa, Yoshihisa Kodera, Shunichi Kato, Yasuo Morishima, Hisamaru Hirai

Blood (2004) 103 (5): 1955–1960.

https://doi.org/10.1182/blood-2003-03-0937

Published: 2004

Journal Articles

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

Hiroyasu Ogawa, Hiroya Tamaki, Kazuhiro Ikegame, Toshihiro Soma, Manabu Kawakami, Akihiro Tsuboi, Eui Ho Kim, Naoki Hosen, Masaki Murakami, Tatsuya Fujioka, Tomoki Masuda, Yuki Taniguchi, Sumiyuki Nishida, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama

Blood (2003) 101 (5): 1698–1704.

https://doi.org/10.1182/blood-2002-06-1831

Published: 2003

Journal Articles

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

Blood (2002) 99 (9): 3272–3279.

https://doi.org/10.1182/blood.V99.9.3272

Published: 2002

NARROW

Peri-Transplant Steroids Enhance GVL and Attenuate GVHD By Redistributing Alloreactive Donor T Cells from the Gut into the Bone Marrow

Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia Harboring t(7;11)(p15;p15)

The Safety of Hematopoietic Stem Cell Harvest from Elderly Family Donor in Japan

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation: A Multi-Center Study in Japan

Second Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Relapse of Hematological Malignancies after First Allo-HSCT

Influence Of Donor Source On Relapse and Survival In Patients With Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis From The Japan Society For Hematopoietic Cell Transplantation (JSHCT) AML Working Group

FDG-PET/CT Early After 90Y-Ibritumomab Tiuxetan Therapy Predicts Outcome in Relapsed or Refractory Indolent B-Cell Lymphoma

A Novel Regimen of Unmanipulated HLA-Haploidentical Transplantation Using a Small Dose of Anti-T-Lymphocyte Globulin for Patients in High Tumor Burden

Novel Strategy for MDS with Thalidomide, 5-Azacitidine and Stem Cell Transplantaion

Unmanipulated HLA-Haploidentical (2-3 antigen-mismatched) Stem Cell Transplantation Using Myeloablative or Reduced-Intensity Preconditioning Regimen,

Prognostic Factors of Reducing Relapse in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation From Related Donor for Acute Myeloid Leukemia: The Japan Society for Hematopoietic Cell Transplantation (JSHCT) AML Working Group

Prospective Isolation and Functional Characterization of Human Bone Marrow-Derived Hematopoietic Stem Cell-Supportive Mesenchymal Stromal Cells.

Mechanism of Marked Reduction In the Severity of Graft-Versus-Host Disease by Reduced-Intensity Conditioning In Murine MHC-Haploidentical BMT Model

Allogeneic stem cell transplantation for adult Philadelphia chromosome–negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission

Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes

Association of TLR-4 Mutations in Host and Donor Cells and the Risk for Acute GVHD after Allogeneic Hematopoietic Stem Cell Transplantation.

Infusions of Fresh Frozen Plasma to the Patients with a High-Risk Group for Hepatic VOD Associated with Stem Cell Transplantation Reduce Its Occurrence.

Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only